Healthcare Stocks Still Holding Slim Gains; Progenics Pharma Adds 4% After Re-Starting Azedra Study


Top Healthcare Stocks

JNJ +0.32%

PFE +0.14%

ABT -0.51%

MRK +1.46%

AMGN +0.56%

Healthcare stocks are holding on to finish higher today with the NYSE Healthcare Sector Index advancing 0.1% and shares of healthcare companies in the S&P 500 adding 0.3% as a group.

In company news, Shares of Progenics Pharmaceuticals Inc. ( PGNX ) is finishing nearly 4% today to $4.78 a share after the biopharmaceutical company said it is resuming a Phase IIb study of its Azedra-targeted radiotherapy in patients suffering from rare endocrine tumors called pheochromocytomas.

Azedra originally was developed by the company's Molecular Insight Pharmaceuticals subsidiary, which began the study under a 2009 Special Protocol Assessment from the Food and Drug Administration. In late 2010, MIP suspended the trial with enrollment two-thirds complete in order to seek additional funding.

In other sector news,

(+) PBMD, Shares rally as much as 76% following a presentation by the Australian biotech's CEO on its prospective cancer vaccine as part of broader presentation this morning on immunocellular cell therapy at an industry conference in London.

(-) CLDX, Said interim data from ongoing Phase II testing of its rindopepimut drug candidate in patients with recurrent glioblastoma showed promising signs of clinical activity in advanced patient populations.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Copyright (C) 2014 All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , Commodities

Referenced Stocks: PGNX

MT Newswires

MT Newswires

More from MT Newswires:

Related Videos



Most Active by Volume

  • $17.88 ▼ 1.38%
  • $18.51 ▼ 6.98%
  • $94.01 ▼ 1.26%
  • $121.30 ▼ 0.87%
  • $23.28 ▼ 9.17%
  • $14.20 ▼ 0.77%
  • $14.83 ▼ 1.79%
  • $46.70 ▼ 0.38%
As of 7/31/2015, 04:15 PM

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by